Bio-Path Holdings, Inc. 8-K Report: Key Updates for Investors

Based on the provided section of the financial report, here are the key pieces of information extracted:
- Entity Information:
- Company Name: Bio-Path Holdings, Inc.
- CIK: 0001133818
- Incorporation State: Delaware (DE)
- SEC File Number: 001-36333
- EIN: 87-0652870
- Address and Contact:
- Address: 4710 Bellaire Boulevard, Suite 210, Bellaire, TX 77401
- Phone Number: 832 742-1357
- Filing Details:
- Filing Type: 8-K (a report of unscheduled material events or corporate changes)
- Filing Date: February 14, 2025
- Securities Information:
- Common Stock: Par value of $0.001 per share
- Ticker Symbol: BPTH
- Exchange: NASDAQ
- Period Covered:
- Start Date: February 14, 2025
- End Date: February 14, 2025
Insights:
- The company is publicly traded on NASDAQ under the ticker BPTH, which indicates its accessibility to investors.
- The filing type (8-K) suggests that there could be significant updates or events pertinent to investors occurring on the date of the report.
- The entity is registered in Delaware, a common state for incorporation due to favorable corporate laws.
This information could be important for investors or analysts looking to understand recent developments or corporate actions related to Bio-Path Holdings, Inc.